Acceptance of intradermal inactivated influenza vaccines among hospital staff following 2 seasonal vaccination campaigns.
Identifieur interne : 000250 ( Main/Exploration ); précédent : 000249; suivant : 000251Acceptance of intradermal inactivated influenza vaccines among hospital staff following 2 seasonal vaccination campaigns.
Auteurs : Laura Goodliffe [Canada] ; Brenda L. Coleman [Canada] ; Allison J. Mcgeer [Canada]Source :
- Human vaccines & immunotherapeutics [ 2164-554X ] ; 2015.
Descripteurs français
- KwdFr :
- Acceptation des soins par les patients (psychologie), Canada (MeSH), Grippe humaine (prévention et contrôle), Humains (MeSH), Hôpitaux (MeSH), Injections intradermiques (MeSH), Personnel médical hospitalier (psychologie), Vaccination (statistiques et données numériques), Vaccins antigrippaux (usage thérapeutique), Vaccins inactivés (usage thérapeutique).
- MESH :
- prévention et contrôle : Grippe humaine.
- psychologie : Acceptation des soins par les patients, Personnel médical hospitalier.
- statistiques et données numériques : Vaccination.
- usage thérapeutique : Vaccins antigrippaux, Vaccins inactivés.
- Canada, Humains, Hôpitaux, Injections intradermiques.
- Wicri :
- geographic : Canada.
English descriptors
- KwdEn :
- Canada (MeSH), Hospitals (MeSH), Humans (MeSH), Influenza Vaccines (therapeutic use), Influenza, Human (prevention & control), Injections, Intradermal (MeSH), Medical Staff, Hospital (psychology), Patient Acceptance of Health Care (psychology), Vaccination (statistics & numerical data), Vaccines, Inactivated (therapeutic use).
- MESH :
- chemical , therapeutic use : Influenza Vaccines, Vaccines, Inactivated.
- geographic : Canada.
- prevention & control : Influenza, Human.
- psychology : Medical Staff, Hospital, Patient Acceptance of Health Care.
- statistics & numerical data : Vaccination.
- Hospitals, Humans, Injections, Intradermal.
Abstract
After a Canadian hospital's official influenza vaccination campaign concluded in the 2011-2012 and 2012-2013 influenza seasons, study nurses provided additional vaccination mobile cart hours and the added choice of an intradermal injection. An additional 2.1% of staff in the first and 1.4% in the second season were vaccinated during the study with 90-99% preferring the intradermal injection or having no preference. All 13 staff who attempted self-injection with the intradermal vaccine in 2012-2013 were successful on their first attempt. Offering alternatives to intramuscular vaccines may increase rates of vaccination.
DOI: 10.1080/21645515.2015.1072665
PubMed: 26378778
PubMed Central: PMC5054788
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Acceptance of intradermal inactivated influenza vaccines among hospital staff following 2 seasonal vaccination campaigns.</title><author><name sortKey="Goodliffe, Laura" sort="Goodliffe, Laura" uniqKey="Goodliffe L" first="Laura" last="Goodliffe">Laura Goodliffe</name><affiliation wicri:level="1"><nlm:affiliation>a Infectious Disease Epidemiology Research Unit; Mount Sinai Hospital ; Toronto , Ontario , Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>a Infectious Disease Epidemiology Research Unit; Mount Sinai Hospital ; Toronto , Ontario </wicri:regionArea><wicri:noRegion>Ontario </wicri:noRegion></affiliation></author><author><name sortKey="Coleman, Brenda L" sort="Coleman, Brenda L" uniqKey="Coleman B" first="Brenda L" last="Coleman">Brenda L. Coleman</name><affiliation wicri:level="1"><nlm:affiliation>a Infectious Disease Epidemiology Research Unit; Mount Sinai Hospital ; Toronto , Ontario , Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>a Infectious Disease Epidemiology Research Unit; Mount Sinai Hospital ; Toronto , Ontario </wicri:regionArea><wicri:noRegion>Ontario </wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:affiliation>b Dalla Lana School of Public Health; University of Toronto ; Toronto , Ontario , Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>b Dalla Lana School of Public Health; University of Toronto ; Toronto , Ontario </wicri:regionArea><wicri:noRegion>Ontario </wicri:noRegion></affiliation></author><author><name sortKey="Mcgeer, Allison J" sort="Mcgeer, Allison J" uniqKey="Mcgeer A" first="Allison J" last="Mcgeer">Allison J. Mcgeer</name><affiliation wicri:level="1"><nlm:affiliation>b Dalla Lana School of Public Health; University of Toronto ; Toronto , Ontario , Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>b Dalla Lana School of Public Health; University of Toronto ; Toronto , Ontario </wicri:regionArea><wicri:noRegion>Ontario </wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:affiliation>c Infection Prevention and Control; Mount Sinai Hospital ; Toronto , Ontario , Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>c Infection Prevention and Control; Mount Sinai Hospital ; Toronto , Ontario </wicri:regionArea><wicri:noRegion>Ontario </wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:26378778</idno><idno type="pmid">26378778</idno><idno type="doi">10.1080/21645515.2015.1072665</idno><idno type="pmc">PMC5054788</idno><idno type="wicri:Area/Main/Corpus">000193</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000193</idno><idno type="wicri:Area/Main/Curation">000193</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000193</idno><idno type="wicri:Area/Main/Exploration">000193</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Acceptance of intradermal inactivated influenza vaccines among hospital staff following 2 seasonal vaccination campaigns.</title><author><name sortKey="Goodliffe, Laura" sort="Goodliffe, Laura" uniqKey="Goodliffe L" first="Laura" last="Goodliffe">Laura Goodliffe</name><affiliation wicri:level="1"><nlm:affiliation>a Infectious Disease Epidemiology Research Unit; Mount Sinai Hospital ; Toronto , Ontario , Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>a Infectious Disease Epidemiology Research Unit; Mount Sinai Hospital ; Toronto , Ontario </wicri:regionArea><wicri:noRegion>Ontario </wicri:noRegion></affiliation></author><author><name sortKey="Coleman, Brenda L" sort="Coleman, Brenda L" uniqKey="Coleman B" first="Brenda L" last="Coleman">Brenda L. Coleman</name><affiliation wicri:level="1"><nlm:affiliation>a Infectious Disease Epidemiology Research Unit; Mount Sinai Hospital ; Toronto , Ontario , Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>a Infectious Disease Epidemiology Research Unit; Mount Sinai Hospital ; Toronto , Ontario </wicri:regionArea><wicri:noRegion>Ontario </wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:affiliation>b Dalla Lana School of Public Health; University of Toronto ; Toronto , Ontario , Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>b Dalla Lana School of Public Health; University of Toronto ; Toronto , Ontario </wicri:regionArea><wicri:noRegion>Ontario </wicri:noRegion></affiliation></author><author><name sortKey="Mcgeer, Allison J" sort="Mcgeer, Allison J" uniqKey="Mcgeer A" first="Allison J" last="Mcgeer">Allison J. Mcgeer</name><affiliation wicri:level="1"><nlm:affiliation>b Dalla Lana School of Public Health; University of Toronto ; Toronto , Ontario , Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>b Dalla Lana School of Public Health; University of Toronto ; Toronto , Ontario </wicri:regionArea><wicri:noRegion>Ontario </wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:affiliation>c Infection Prevention and Control; Mount Sinai Hospital ; Toronto , Ontario , Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>c Infection Prevention and Control; Mount Sinai Hospital ; Toronto , Ontario </wicri:regionArea><wicri:noRegion>Ontario </wicri:noRegion></affiliation></author></analytic><series><title level="j">Human vaccines & immunotherapeutics</title><idno type="eISSN">2164-554X</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Canada (MeSH)</term><term>Hospitals (MeSH)</term><term>Humans (MeSH)</term><term>Influenza Vaccines (therapeutic use)</term><term>Influenza, Human (prevention & control)</term><term>Injections, Intradermal (MeSH)</term><term>Medical Staff, Hospital (psychology)</term><term>Patient Acceptance of Health Care (psychology)</term><term>Vaccination (statistics & numerical data)</term><term>Vaccines, Inactivated (therapeutic use)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Acceptation des soins par les patients (psychologie)</term><term>Canada (MeSH)</term><term>Grippe humaine (prévention et contrôle)</term><term>Humains (MeSH)</term><term>Hôpitaux (MeSH)</term><term>Injections intradermiques (MeSH)</term><term>Personnel médical hospitalier (psychologie)</term><term>Vaccination (statistiques et données numériques)</term><term>Vaccins antigrippaux (usage thérapeutique)</term><term>Vaccins inactivés (usage thérapeutique)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Influenza Vaccines</term><term>Vaccines, Inactivated</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Canada</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" qualifier="psychologie" xml:lang="fr"><term>Acceptation des soins par les patients</term><term>Personnel médical hospitalier</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Medical Staff, Hospital</term><term>Patient Acceptance of Health Care</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Vaccination</term></keywords><keywords scheme="MESH" qualifier="statistiques et données numériques" xml:lang="fr"><term>Vaccination</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Vaccins antigrippaux</term><term>Vaccins inactivés</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Hospitals</term><term>Humans</term><term>Injections, Intradermal</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Canada</term><term>Humains</term><term>Hôpitaux</term><term>Injections intradermiques</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Canada</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">After a Canadian hospital's official influenza vaccination campaign concluded in the 2011-2012 and 2012-2013 influenza seasons, study nurses provided additional vaccination mobile cart hours and the added choice of an intradermal injection. An additional 2.1% of staff in the first and 1.4% in the second season were vaccinated during the study with 90-99% preferring the intradermal injection or having no preference. All 13 staff who attempted self-injection with the intradermal vaccine in 2012-2013 were successful on their first attempt. Offering alternatives to intramuscular vaccines may increase rates of vaccination. </div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26378778</PMID><DateCompleted><Year>2016</Year><Month>09</Month><Day>26</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2164-554X</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>12</Issue><PubDate><Year>2015</Year></PubDate></JournalIssue><Title>Human vaccines & immunotherapeutics</Title><ISOAbbreviation>Hum Vaccin Immunother</ISOAbbreviation></Journal><ArticleTitle>Acceptance of intradermal inactivated influenza vaccines among hospital staff following 2 seasonal vaccination campaigns.</ArticleTitle><Pagination><MedlinePgn>2827-30</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/21645515.2015.1072665</ELocationID><Abstract><AbstractText>After a Canadian hospital's official influenza vaccination campaign concluded in the 2011-2012 and 2012-2013 influenza seasons, study nurses provided additional vaccination mobile cart hours and the added choice of an intradermal injection. An additional 2.1% of staff in the first and 1.4% in the second season were vaccinated during the study with 90-99% preferring the intradermal injection or having no preference. All 13 staff who attempted self-injection with the intradermal vaccine in 2012-2013 were successful on their first attempt. Offering alternatives to intramuscular vaccines may increase rates of vaccination. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Goodliffe</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>a Infectious Disease Epidemiology Research Unit; Mount Sinai Hospital ; Toronto , Ontario , Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coleman</LastName><ForeName>Brenda L</ForeName><Initials>BL</Initials><AffiliationInfo><Affiliation>a Infectious Disease Epidemiology Research Unit; Mount Sinai Hospital ; Toronto , Ontario , Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>b Dalla Lana School of Public Health; University of Toronto ; Toronto , Ontario , Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McGeer</LastName><ForeName>Allison J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>b Dalla Lana School of Public Health; University of Toronto ; Toronto , Ontario , Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>c Infection Prevention and Control; Mount Sinai Hospital ; Toronto , Ontario , Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>09</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Hum Vaccin Immunother</MedlineTA><NlmUniqueID>101572652</NlmUniqueID><ISSNLinking>2164-5515</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015164">Vaccines, Inactivated</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002170" MajorTopicYN="N" Type="Geographic">Canada</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006761" MajorTopicYN="N">Hospitals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007271" MajorTopicYN="N">Injections, Intradermal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008505" MajorTopicYN="N">Medical Staff, Hospital</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010342" MajorTopicYN="N">Patient Acceptance of Health Care</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015164" MajorTopicYN="N">Vaccines, Inactivated</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">healthcare</Keyword><Keyword MajorTopicYN="N">hospital</Keyword><Keyword MajorTopicYN="N">immunization program</Keyword><Keyword MajorTopicYN="N">influenza vaccines</Keyword><Keyword MajorTopicYN="N">intradermal</Keyword><Keyword MajorTopicYN="N">pain perception</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>9</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>9</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>9</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26378778</ArticleId><ArticleId IdType="doi">10.1080/21645515.2015.1072665</ArticleId><ArticleId IdType="pmc">PMC5054788</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>BMC Med. 2009 Apr 02;7:13</Citation><ArticleIdList><ArticleId IdType="pubmed">19341446</ArticleId></ArticleIdList></Reference><Reference><Citation>Adv Ther. 2012 Jan;29(1):41-52</Citation><ArticleIdList><ArticleId IdType="pubmed">22228256</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Control Hosp Epidemiol. 2000 Nov;21(11):730-2</Citation><ArticleIdList><ArticleId IdType="pubmed">11089659</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Prev Med. 2010 Mar;38(3):237-46</Citation><ArticleIdList><ArticleId IdType="pubmed">20036102</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2012 Jan;12(1):36-44</Citation><ArticleIdList><ArticleId IdType="pubmed">22032844</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Control Hosp Epidemiol. 2008 Apr;29(4):302-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18462141</ArticleId></ArticleIdList></Reference><Reference><Citation>Adv Ther. 2011 Aug;28(8):640-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21751080</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Infect Control. 2007 Feb;35(1):33-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17276789</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2008 Oct 23;13(43):null</Citation><ArticleIdList><ArticleId IdType="pubmed">18947524</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Vaccin Immunother. 2013 Sep;9(9):1971-7</Citation><ArticleIdList><ArticleId IdType="pubmed">23778938</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2012 Sep 28;30(44):6287-93</Citation><ArticleIdList><ArticleId IdType="pubmed">22902784</ArticleId></ArticleIdList></Reference><Reference><Citation>Adv Ther. 2012 Jun;29(6):562-77</Citation><ArticleIdList><ArticleId IdType="pubmed">22678831</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2008 Jun 19;26(26):3197-208</Citation><ArticleIdList><ArticleId IdType="pubmed">18486285</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Infect Control. 2009 Fall;24(3):159-64</Citation><ArticleIdList><ArticleId IdType="pubmed">19891169</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Canada</li></country></list><tree><country name="Canada"><noRegion><name sortKey="Goodliffe, Laura" sort="Goodliffe, Laura" uniqKey="Goodliffe L" first="Laura" last="Goodliffe">Laura Goodliffe</name></noRegion><name sortKey="Coleman, Brenda L" sort="Coleman, Brenda L" uniqKey="Coleman B" first="Brenda L" last="Coleman">Brenda L. Coleman</name><name sortKey="Coleman, Brenda L" sort="Coleman, Brenda L" uniqKey="Coleman B" first="Brenda L" last="Coleman">Brenda L. Coleman</name><name sortKey="Mcgeer, Allison J" sort="Mcgeer, Allison J" uniqKey="Mcgeer A" first="Allison J" last="Mcgeer">Allison J. Mcgeer</name><name sortKey="Mcgeer, Allison J" sort="Mcgeer, Allison J" uniqKey="Mcgeer A" first="Allison J" last="Mcgeer">Allison J. Mcgeer</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeCanadaV4/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000250 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000250 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippeCanadaV4
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:26378778
|texte= Acceptance of intradermal inactivated influenza vaccines among hospital staff following 2 seasonal vaccination campaigns.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:26378778" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeCanadaV4
| This area was generated with Dilib version V0.6.35. |  |